NB02(POSELTINIB) Monotherapy in R/R Non-Hodgkin's Lymphoma

Clinical trial NCT07114367 · RECRUITING

Trial details

NCT number: NCT07114367
Sponsor: NOBO Medicine
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non Hodgkin Lymphoma (NHL)

Start date: 2025-12-02
Primary completion: 2026-12-31
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.